__NUXT_JSONP__("/drugs/Tivozanib", (function(a,b){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"475108-18-0",chebiId:"",chemicalFormula:"C22H19ClN4O5",definition:"An orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities.  Tivozanib binds to and inhibits VEGFRs 1, 2 and 3, which may result in the inhibition of endothelial cell migration and proliferation, inhibition of tumor angiogenesis and tumor cell death. VEGFR tyrosine kinases, frequently overexpressed by a variety of tumor cell types, play a key role in angiogenesis.",fdaUniiCode:"172030934T",identifier:"C85444",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C93259"],synonyms:["AV-951","TIVOZANIB",a,"Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FTivozanib",extension:".json",createdAt:b,updatedAt:b}}],fetch:{},mutations:void 0}}("Tivozanib","2021-10-30T13:46:26.103Z")));